With years of experience in healthcare management, Olamide Omotosho is reshaping Nigeria’s medical supply chains by shifting it away from efficiency-driven logistics to resilience-focused systems critical to patient care and health security.
She underscored the vulnerability of efficiency-driven medical supply chains, warning that repeated global disruptions have exposed structural weaknesses that threaten continuity of care and erode public trust.
Omotosho explained that shortages of essential medical products, delayed deliveries, and breakdowns in coordination have shown how systems optimised mainly for speed and cost often lack the flexibility required during sustained crises.
She noted that as healthcare systems become increasingly interconnected, these failures carry serious consequences not only for patients but also for workforce stability and overall system confidence.
The healthcare strategist emphasised that these realities are driving renewed scrutiny of how medical supply chains are designed and governed. Long treated as background logistics functions, supply chains are now being recognised as essential public health systems whose failure can directly undermine health outcomes.
She added that the growing focus on resilience reflects a broader understanding that efficiency alone is no longer adequate for healthcare preparedness.
She outlined the need for a fundamental shift in approach, moving away from managing shortages as episodic emergencies toward resilience-focused preparedness built on anticipatory planning, predictive risk assessment, and continuous oversight.
Essential medical products, she said, must be treated as strategic assets requiring proactive governance rather than crisis-driven intervention.
Central to this redefinition, she said, is the integration of multiple risk dimensions into a single preparedness framework. These include clinical criticality, manufacturing concentration, geopolitical exposure, logistics constraints, and operational dependencies.
Omotosho explained that assessing these risks together allows decision-makers to identify which supplies pose the greatest threat if disrupted and to prioritise resources more effectively to protect patient safety and system continuity.
Coordination also featured prominently in her remarks. Medical supply chains, she observed, span manufacturers, distributors, healthcare providers, and multiple layers of government, yet often operate with fragmented visibility and unclear escalation pathways.
She noted that unified operational approaches, supported by shared thresholds and response protocols, are critical to improving alignment and reducing delays during periods of stress.
Omotosho noted that shifting the focus from efficiency to resilience elevates medical supply chain preparedness beyond an operational concern to a strategic component of national health security, particularly as disruptions become more frequent and complex.
Omotosho is a seasoned healthcare program and strategy leader with experience spanning frontline care, business strategy, and technology-enabled program management, bringing a human-centred and data-informed perspective to strengthening medical supply chain preparedness.
